The 5-year survival rate of ovarian adenocarcinoma is usually 30% to 90%. Ovarian adenocarcinoma belongs to a kind of ovarian cancer, which originates from ovarian epithelial cells and mainly includes plasma cystadenocarcinoma and mucinous cystadenocarcinoma. Early stage usually has no obvious symptoms, so it is not easy to be detected, and late stage has atypical clinical symptoms. Surgery is usually adopted as the main treatment option, with high recurrence rate after surgery, and the prognosis is related to the tumor pathology type, stage, and personal situation. Ovarian adenocarcinoma is divided into four stages, the 5-year survival rate of early ovarian adenocarcinoma can reach 90%, which is obviously higher than that of middle and late stage, and the 5-year survival rate of middle and late stage can reach 30% to 90%, and its survival time mainly depends on the staging and treatment, so it is recommended that patients consult the doctor in time for symptomatic treatment.